- Case note: CJEU (Synthetic marijuana not a "medicinal product")
- Case no.
- Case date
- 10 July 2014
- European Journal of Risk Regulation: 1867-299X
- Volume | Edition (Serie)
- 2014 | 4
- Document type
- Case note
- Faculty of Law (FdR)
- Centre for the Study of European Contract Law (CSECL)
- Page from: 548
Page to: 552
Joined Cases C-358/13 and C-181/14, Markus D. and G. Substances which produce effects that merely modify physiological functions but which are not such as to have any beneficial effects, either immediately or in the long term, on human health, are consumed solely to induce a state of intoxication and are, as such, harmful to human health do not fall within the scope of the definition of a "medicinal product" in the Directive 2001/83 (official headnote). Consumer safety and medicines control legislation is not suitable to penalise the introduction of new psychoactive substances on European markets (author’s headnote). Art 1(2)(b) Directive 2001/83.
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.